LMR Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
LMR Partners's NVS Position: Q1 2026 in Review
LMR Partners opened a new position in Novartis (NVS) in Q1 2026: 43,105 shares worth $6.58M. The stake represents 0.01% of the portfolio and ranks #555 among its holdings. This is a return to the name: LMR Partners previously reported a position in NVS as recently as Q2 2023.
LMR Partners first reported a position in NVS in Q2 2023 and has held it in 2 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- LMR Partners held 43,105 shares of Novartis worth $6.58M as of Q1 2026.
- Novartis was a new LMR Partners position in Q1 2026.
- Novartis made up 0.01% of LMR Partners's portfolio in Q1 2026, its #555 holding.
- LMR Partners first reported a position in Novartis in Q2 2023 and has held it in 2 quarters since.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.